Literature DB >> 12036938

Ectopic expression of a COOH-terminal fragment of the human telomerase reverse transcriptase leads to telomere dysfunction and reduction of growth and tumorigenicity in HeLa cells.

Jun Jian Huang1, Marie C Lin, Yun Xiu Bai, Da Dao Jing, Benjamin C Y Wong, Su Wen Han, Jian Lin, Bing Xu, Cui-Fen Huang, Hsiang-Fu Kung.   

Abstract

The COOH-terminus of telomerase reverse transcriptase (hTERT) has been shown to participatein the nuclear translocation of TERT. Here, we constructed plasmids expressing the COOH-terminal M(r) 27,000 polypeptide of hTERT (hTERTC27) withthe telomerase RNA-binding domains and the reverse transcriptase domains deleted. We showed that ectopic overexpression of this polypeptide caused a defect in telomere maintenance in hTERT-positive HeLa cells, which led to senescence-like growth arrest and apoptosis. The hTERTC27 appears to work by inducing telomere dysfunction, exemplified by significantly increased anaphase chromosome end-to-end fusion events in transfected cells. Significantly, it had no effect on the cellular telomerase enzymatic activity or telomere length. The in vivo effect was further demonstrated as HeLa cells stably expressing hTERTC27 have significantly lower growth rate and reduced tumorigenicity in nude mice xenografts. Results from this study revealed an important function for the COOH terminus of hTERT in maintaining the integrity of telomere structure and chromosome ends, as well as in cell senescence and apoptosis. Furthermore, hTERTC27 provides a new strategy for cancer therapy by inducing telomere dysfunction in cancer cells without affecting the telomerase enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12036938

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  The helicase protein DHX29 promotes translation initiation, cell proliferation, and tumorigenesis.

Authors:  Armen Parsyan; David Shahbazian; Yvan Martineau; Emmanuel Petroulakis; Tommy Alain; Ola Larsson; Geraldine Mathonnet; Gritta Tettweiler; Christopher U Hellen; Tatyana V Pestova; Yuri V Svitkin; Nahum Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-11       Impact factor: 11.205

Review 2.  Telomerase gene therapy: a remission toward cancer.

Authors:  Sameer Quazi
Journal:  Med Oncol       Date:  2022-04-16       Impact factor: 3.064

3.  Inhibition of melanoma growth by subcutaneous administration of hTERTC27 viral cocktail in C57BL/6 mice.

Authors:  Longfei Huo; Hong Yao; Xicai Wang; Gee Wan Wong; Hsiang-fu Kung; Marie C Lin
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

4.  The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity.

Authors:  Sylvain Huard; Tara J Moriarty; Chantal Autexier
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

5.  Early growth response protein-1 promoter-mediated synergistic antitumor effect of hTERTC27 gene therapy and 5-Flurorouracil on nasopharyngeal carcinoma.

Authors:  Guimiao Lin; Marie Chia-Mi Lin; Suxia Lin; Hong Yao; Shuihong Yu; Wanxian Yi; Gaixia Xu; Samuel Sai-Ming Ng; Siping Chen; Jing Yu; Xiaomei Wang; Baoxue Yang
Journal:  Cancer Biother Radiopharm       Date:  2012-09       Impact factor: 3.099

6.  Effective antitumor immunity against murine gliomas using dendritic cells transduced with hTERTC27 recombinant adenovirus.

Authors:  Han-Xian Gong; Lei He; Xiang-Pen Li; Yi-Dong Wang; Yi Li; Jun-Jian Huang; Ziling Wang; Dan Xie; Hsiang-Fu Kung; Ying Peng
Journal:  Oncol Rep       Date:  2011-12-30       Impact factor: 3.906

7.  Suppressing tumor growth of nasopharyngeal carcinoma by hTERTC27 polypeptide delivered through adeno-associated virus plus adenovirus vector cocktail.

Authors:  Xiong Liu; Xiang-Ping Li; Ying Peng; Samuel S Ng; Hong Yao; Zi-Feng Wang; Xiao-Mei Wang; Hsiang-Fu Kung; Marie C M Lin
Journal:  Chin J Cancer       Date:  2012-11-13

8.  OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma.

Authors:  Pei-jian Yue; Lei He; Shu-wei Qiu; Yi Li; Yi-ji Liao; Xiang-pen Li; Dan Xie; Ying Peng
Journal:  Mol Cancer       Date:  2014-08-13       Impact factor: 27.401

Review 9.  Biology of high single doses of IORT: RBE, 5 R's, and other biological aspects.

Authors:  Carsten Herskind; Lin Ma; Qi Liu; Bo Zhang; Frank Schneider; Marlon R Veldwijk; Frederik Wenz
Journal:  Radiat Oncol       Date:  2017-01-19       Impact factor: 3.481

10.  Inhibition of hepatocellular carcinoma growth by adenovirus-mediated expression of human telomerase reverse transcriptase COOH-27 terminal polypeptide in mice.

Authors:  Lei He; Han-Xian Gong; Xiang-Pen Li; Yi-Dong Wang; Yi Li; Jun-Jian Huang; Dan Xie; Hsiang-Fu Kung; Ying Peng
Journal:  Oncol Lett       Date:  2013-07-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.